{
    "2020-10-30": [
        [
            {
                "time": "2021-10-15",
                "original_text": "Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study",
                "features": {
                    "keywords": [
                        "Q3 Earnings",
                        "AZN/JNJ",
                        "Coronavirus Vaccine",
                        "Resumption"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-16",
                "original_text": "Pharmaceutical Industry Leaders Target Cutting-Edge MS Treatments That Once Were 'Fantasy'",
                "features": {
                    "keywords": [
                        "Cutting-Edge",
                        "MS Treatments",
                        "Pharmaceutical Industry"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-17",
                "original_text": "Novartis expands KymriahÂ® manufacturing footprint with first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Kymriah",
                        "CAR-T",
                        "Asia",
                        "Manufacturing"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}